Influenza-Induced Priming and Leak of Human Lung Microvascular Endothelium upon Exposure to Staphylococcus aureus.

A major cause of death after influenza virus infection is lung injury due to a bacterial superinfection, yet the mechanism is unknown. Death has been attributed to virus-induced immunosuppression and bacterial overgrowth, but this hypothesis is based on data from the preantibiotic era and animal models that omit antimicrobial therapy. Because of diagnostic uncertainty, most patients with influenza receive antibiotics, making bacterial overgrowth unlikely. Respiratory failure after superinfection presents as acute respiratory distress syndrome, a disorder characterized by lung microvascular leak and edema. The objective of this study was to determine whether the influenza virus sensitizes the lung endothelium to leak upon exposure to circulating bacterial-derived molecular patterns from Staphylococcus aureus. In vitro as well as in vivo models of influenza followed by S. aureus superinfection were used. Molecular mechanisms were explored using molecular biology, knockout mice, and human autopsy specimens. Influenza virus infection sensitized human lung endothelium to leak when challenged with S. aureus, even at low doses of influenza and even when the pathogens were given days apart. Influenza virus increased endothelial expression of TNFR1 both in vitro and in intact lungs, a finding corroborated by human autopsy specimens of patients with influenza. Leak was recapitulated with protein A, a TNFR1 ligand, and sequential infection caused protein A-dependent loss of IκB, cleavage of caspases 8 and 3, and lung endothelial apoptosis. Mice infected sequentially with influenza virus and S. aureus developed significantly increased lung edema that was protein A and TNFR1 dependent. Influenza virus primes the lung endothelium to leak, predisposing patients to acute respiratory distress syndrome upon exposure to S. aureus.

[1]  J. McCullers The co-pathogenesis of influenza viruses with bacteria in the lung , 2014, Nature Reviews Microbiology.

[2]  D. Missiakas,et al.  Release of protein A from the cell wall of Staphylococcus aureus , 2014, Proceedings of the National Academy of Sciences.

[3]  D. Cook,et al.  The occurrence and impact of bacterial organisms complicating critical care illness associated with 2009 influenza A(H1N1) infection. , 2013, Chest.

[4]  T. Moraes,et al.  Influenza Infects Lung Microvascular Endothelium Leading to Microvascular Leak: Role of Apoptosis and Claudin-5 , 2012, PloS one.

[5]  A. Nicholson,et al.  A Key Role for the Endothelium in NOD1 Mediated Vascular Inflammation: Comparison to TLR4 Responses , 2012, PloS one.

[6]  Arthur S Slutsky,et al.  Acute Respiratory Distress Syndrome The Berlin Definition , 2012 .

[7]  W. Kuebler,et al.  Co‐regulation of Transcellular and Paracellular Leak Across Microvascular Endothelium By Dynamin and Rac , 2012, The American journal of pathology.

[8]  Robert Peach,et al.  Endothelial Cells Are Central Orchestrators of Cytokine Amplification during Influenza Virus Infection , 2011, Cell.

[9]  A. Shorr,et al.  Bacteremia in Staphylococcus aureus pneumonia: outcomes and epidemiology. , 2011, Journal of critical care.

[10]  S. Akira,et al.  Viral infection augments Nod1/2 signaling to potentiate lethality associated with secondary bacterial infections. , 2011, Cell host & microbe.

[11]  K. Horiuchi,et al.  Activation of TNFR1 ectodomain shedding by mitochondrial Ca2+ determines the severity of inflammation in mouse lung microvessels. , 2011, The Journal of clinical investigation.

[12]  J. Davies,et al.  Modulation of virulence gene expression by cell wall active antibiotics in Staphylococcus aureus. , 2011, The Journal of antimicrobial chemotherapy.

[13]  W. Liles,et al.  Endothelial activation, dysfunction and permeability during severe infections , 2011, Current opinion in hematology.

[14]  Arthur S Slutsky,et al.  Physiologic and Biologic Characteristics of Three Experimental Models of Acute Lung Injury in Rats , 2011, Anesthesia and analgesia.

[15]  Kelli L Boyd,et al.  Influenza virus primes mice for pneumonia from Staphylococcus aureus. , 2011, The Journal of infectious diseases.

[16]  K. Tominaga,et al.  Corrigendum: Activation of innate immune antiviral responses by Nod2 , 2010, Nature Immunology.

[17]  S. Lapinsky,et al.  Epidemiology of influenza-associated hospitalization in adults, Toronto, 2007/8 , 2010, European Journal of Clinical Microbiology & Infectious Diseases.

[18]  B. Han,et al.  Cardiovascular , Pulmonary and Renal Pathology Functions of Type II Pneumocyte-Derived Vascular Endothelial Growth Factor in Alveolar Structure , Acute Inflammation , and Vascular Permeability , 2010 .

[19]  R. Murray,et al.  Community-Acquired Pneumonia Due to Pandemic A(H1N1)2009 Influenzavirus and Methicillin Resistant Staphylococcus aureus Co-Infection , 2010, PloS one.

[20]  S. Lapinsky,et al.  Critically Ill patients with 2009 influenza A(H1N1) in Mexico. , 2009, JAMA.

[21]  K. McCullough,et al.  Hemagglutinin-Dependent Tropism of H5N1 Avian Influenza Virus for Human Endothelial Cells , 2009, Journal of Virology.

[22]  P. Murray Beyond peptidoglycan for Nod2 , 2009, Nature Immunology.

[23]  G. Núñez,et al.  A Critical Role for Hemolysins and Bacterial Lipoproteins in Staphylococcus aureus-Induced Activation of the Nlrp3 Inflammasome1 , 2009, The Journal of Immunology.

[24]  K. Connelly,et al.  The (Pro)Renin Receptor: Site-Specific and Functional Linkage to the Vacuolar H+-ATPase in the Kidney , 2009, Hypertension.

[25]  S. Fortune,et al.  NOD2, RIP2 and IRF5 Play a Critical Role in the Type I Interferon Response to Mycobacterium tuberculosis , 2009, PLoS pathogens.

[26]  A. Shahangian,et al.  Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. , 2009, The Journal of clinical investigation.

[27]  Anthony S Fauci,et al.  Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. , 2008, The Journal of infectious diseases.

[28]  J. Taubenberger,et al.  Pathology of human influenza revisited. , 2008, Vaccine.

[29]  Jianqiang Ding,et al.  Divergent roles of endothelial NF-κB in multiple organ injury and bacterial clearance in mouse models of sepsis , 2008, The Journal of experimental medicine.

[30]  Thomas D. Schmittgen,et al.  Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.

[31]  J. Taubenberger,et al.  The pathology of influenza virus infections. , 2008, Annual review of pathology.

[32]  T. Mak,et al.  RIP2 contributes to Nod signaling but is not essential for T cell proliferation, T helper differentiation or TLR responses , 2008, European journal of immunology.

[33]  J. Raboud,et al.  Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  P. Roberts,et al.  Filamentous Influenza A Virus Infection Predisposes Mice to Fatal Septicemia following Superinfection with Streptococcus pneumoniae Serotype 3 , 2007, Infection and Immunity.

[35]  K. Cox,et al.  Enhancement of Macrophage Stimulation by Lipoteichoic Acid and the Costimulant Hemoglobin Is Dependent on Toll-Like Receptors 2 and 4 , 2007, Infection and Immunity.

[36]  S. Harigopal,et al.  High incidence of pulmonary bacterial co-infection in children with severe respiratory syncytial virus (RSV) bronchiolitis , 2006, Thorax.

[37]  G. Hunninghake,et al.  Respiratory Syncytial Virus Induces TLR3 Protein and Protein Kinase R, Leading to Increased Double-Stranded RNA Responsiveness in Airway Epithelial Cells1 , 2006, The Journal of Immunology.

[38]  Fred C Tenover,et al.  Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. , 2006, The Journal of infectious diseases.

[39]  Diane P. Martin,et al.  Incidence and outcomes of acute lung injury. , 2005, The New England journal of medicine.

[40]  D. Philpott,et al.  Recognition of Staphylococcus aureus by the Innate Immune System , 2005, Clinical Microbiology Reviews.

[41]  T. Uyeki,et al.  A national survey of severe influenza-associated complications among children and adults, 2003-2004. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[42]  Stephen Kent,et al.  The viral mimic, polyinosinic:polycytidylic acid, induces fever in rats via an interleukin-1-dependent mechanism. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[43]  Bharat Reddy,et al.  Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1 , 2004, Nature Medicine.

[44]  J. McCullers,et al.  Respiratory viruses predisposing to bacterial infections: role of neuraminidase , 2004, The Pediatric infectious disease journal.

[45]  J. Tschopp,et al.  Induction of TNF Receptor I-Mediated Apoptosis via Two Sequential Signaling Complexes , 2003, Cell.

[46]  R. Novick Autoinduction and signal transduction in the regulation of staphylococcal virulence , 2003, Molecular microbiology.

[47]  S. Goldblum,et al.  Mechanisms of bacterial lipopolysaccharide-induced endothelial apoptosis. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[48]  Keiji Fukuda,et al.  Mortality associated with influenza and respiratory syncytial virus in the United States. , 2003, JAMA.

[49]  P. Suter,et al.  Tumor Necrosis Factor-α and Angiostatin Are Mediators of Endothelial Cytotoxicity in Bronchoalveolar Lavages of Patients with Acute Respiratory Distress Syndrome , 2002 .

[50]  C. Kirkpatrick,et al.  GM-CSF expression by human lung microvascular endothelial cells: in vitro and in vivo findings. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[51]  Arthur S Slutsky,et al.  Ventilator-induced lung injury and recommendations for mechanical ventilation of patients with ARDS. , 2001, Seminars in respiratory and critical care medicine.

[52]  P. Marik,et al.  Influenza pneumonia: a descriptive study. , 2001, Chest.

[53]  Jean-Yves Fagon,et al.  Ventilator-associated pneumonia. , 2002, American journal of respiratory and critical care medicine.

[54]  Beck,et al.  Release of CXC‐chemokines by human lung microvascular endothelial cells (LMVEC) compared with macrovascular umbilical vein endothelial cells , 1999, Clinical and experimental immunology.

[55]  S. Goldblum,et al.  Bacterial Lipopolysaccharide Disrupts Endothelial Monolayer Integrity and Survival Signaling Events through Caspase Cleavage of Adherens Junction Proteins* , 1998, The Journal of Biological Chemistry.

[56]  C. Cordon-Cardo,et al.  Lipopolysaccharide Induces Disseminated Endothelial Apoptosis Requiring Ceramide Generation , 1997, The Journal of experimental medicine.

[57]  J. Peschon,et al.  Antiviral Activity of Tumor Necrosis Factor (TNF) Is Mediated via p55 and p75 TNF Receptors , 1997, The Journal of experimental medicine.

[58]  J. Heinrichs,et al.  Regulation of protein A synthesis by the sar and agr loci of Staphylococcus aureus , 1997, Infection and immunity.

[59]  I. Mori,et al.  Viremia induced by influenza virus. , 1995, Microbial pathogenesis.

[60]  I. Morita,et al.  IL-6 increases endothelial permeability in vitro. , 1992, Endocrinology.

[61]  S. Albelda,et al.  Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule , 1991, The Journal of cell biology.

[62]  T. Demaria,et al.  Pulmonary Infection of Mice with Staphylococcus aureus , 1978, Infection and immunity.

[63]  Bruce W. Knight,et al.  A MORPHOMETRIC STUDY ON THE THICKNESS OF THE PULMONARY AIR-BLOOD BARRIER , 1964, The Journal of cell biology.

[64]  E. D. Kilbourne,et al.  THE INFLUENCE OF INFLUENZA VIRUS INFECTION ON EXOGENOUS STAPHYLOCOCCAL AND ENDOGENOUS MURINE BACTERIAL INFECTION OF THE BRONCHOPULMONARY TISSUES OF MICE , 1961, The Journal of experimental medicine.

[65]  L. Gottlieb,et al.  Asian influenza A in Boston, 1957-1958. II. Severe staphylococcal pneumonia complicating influenza. , 1959, A.M.A. archives of internal medicine.

[66]  M. Kaji,et al.  Clinicopathologic study of thirty-three fatal cases of Asian influenza. , 1959, The New England journal of medicine.

[67]  Kathy Hancock Influenza A Virus , 2020, Definitions.

[68]  P. Suter,et al.  Tumor necrosis factor-alpha and angiostatin are mediators of endothelial cytotoxicity in bronchoalveolar lavages of patients with acute respiratory distress syndrome. , 2002, American journal of respiratory and critical care medicine.

[69]  D. E. Rogers,et al.  Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza. , 1959, The Journal of clinical investigation.